PROPERTIES OF K+ CURRENT THAT CONTROLS SECRETION

控制分泌的 K 电流的特性

基本信息

项目摘要

In mammals, corticosteroid secretion by cells of the adrenal gland is controlled by peptide hormones including adrenocorticotropic hormone (ACTH) and angiotensin II (AII). Glucocorticoids such as cortisol act on cells of the liver, muscle and adipose tissue to enhance glucose synthesis-and to promote the breakdown of fat and proteins. Aberrant corticosteroid secretion is responsible for serious pathology including Cushing's and Addison's diseases. The mineralocorticoid aldosterone acts to maintain fluid and electrolyte balance. Inappropriate aldolsterone secretion is manifested as hypo- or hypertension. The cellular mechanisms by which peptide hormones regulate corticosteroid secretion are not understood. In many secretory cells, hormone production is coupled to membrane depolarization through activation of voltage-gated Ca2+ channels. Bovine adrenocortical cells possess a novel K+ channel (IAC) that sets the membrane potential of these cells. Importantly, both ACTH and AII inhibit IAC and depolarize adrenal cells at equivalent subnanomolar concentrations. The convergent inhibition of IAC by these two peptides suggests a physiological mechanism whereby biochemical signals at the cell membrane can be coupled to depolarization-dependent Ca2+ entry and steroid hormone secretion. Because IAC appears to act pivotally in transducing biochemical signals to electrical events involved in secretion, a detailed characterization of this current, the underlying channels and the signalling pathways that regulate IAC activity will be essential to understanding adrenal cortical physiology. In the proposed studies, IAC in bovine and human adrenal zona fasciculata cells will be examined with patch voltage clamp techniques. Functional expression of IAC in Xenopus oocytes will be used to clone IAC channel cDNA. The aims of the proposed research will be: 1) To characterize IAC with respect to biophysical properties, pharmacology, and modulation by metabolic factors and enzymes; 2) To identify and characterize the signalling pathways and molecular mechanisms by which ACTH inhibits IAC; 3) To determine whether IAC is present and regulated by AII and ACTH in human adrenocortical cells; 4) To clone and sequence the cDNA for IAC by expression cloning in Xenopus oocytes.
在哺乳动物中,肾上腺细胞的皮质类固醇分泌是 由包括肾上腺皮质激素在内的肽激素控制 (ACTH)和血管紧张素II(AII)。糖皮质激素(例如皮质醇)作用于 肝脏,肌肉和脂肪组织的细胞以增强葡萄糖 合成并促进脂肪和蛋白质的分解。异常 皮质类固醇分泌负责严重的病理学 Cushing和Addison的疾病。矿物皮质激素醛固酮作用 维持流体和电解质平衡。不适当的藻酮 分泌表现为低血压或高血压。 肽激素调节皮质类固醇的细胞机制 分泌不了解。在许多分泌细胞中,激素产生 通过激活电压门控与膜去极化耦合 CA2+通道。牛肾上腺皮质细胞具有新颖的K+通道 (IAC)设定了这些细胞的膜电位。重要的是,两者俩 ACTH和AII抑制IAC并在等效上去极化肾上腺细胞 亚奈摩尔浓度。这些对IAC的收敛抑制 两种肽提出了一种生理机制 细胞膜处的信号可以耦合到去极化依赖性 CA2+进入和类固醇激素分泌。 因为IAC似乎在转导的生化信号中起着关键作用 分泌涉及的电气事件,详细的表征 在此电流中,基础通道和信号通路 调节IAC活性对于理解肾上腺皮质至关重要 生理。 在拟议的研究中,牛和人类肾上腺Zona fasciculata中的IAC 将使用贴片电压夹技术检查细胞。功能 IAC在爪蟾卵母细胞中的表达将用于克隆IAC通道 cDNA。拟议研究的目的将是: 1)为生物物理特性表征IAC, 药理学和代谢因素和酶调节; 2)识别和表征信号通路和分子 ACTH抑制IAC的机制; 3)确定IAC是否存在并受AII和ACTH的调节 人肾上腺皮质细胞; 4)克隆并测序IAC的cDNA 异武卵母细胞中的表达克隆。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据

数据更新时间:2024-06-01

JOHN J ENYEART的其他基金

Properties of Ion Channels that Control Secretion
控制分泌的离子通道的特性
  • 批准号:
    8038532
    8038532
  • 财政年份:
    2010
  • 资助金额:
    $ 14.57万
    $ 14.57万
  • 项目类别:
PROPERTIES OF K+ CURRENT THAT CONTROLS SECRETION
控制分泌的 K 电流的特性
  • 批准号:
    2147783
    2147783
  • 财政年份:
    1995
  • 资助金额:
    $ 14.57万
    $ 14.57万
  • 项目类别:
PROPERTIES OF A K+ CURRENT THAT CONTROLS SECRECTION
控制节流的 AK 电流的特性
  • 批准号:
    6329389
    6329389
  • 财政年份:
    1995
  • 资助金额:
    $ 14.57万
    $ 14.57万
  • 项目类别:
PROPERTIES OF A K+ CURRENT THAT CONTROLS SECRECTION
控制节流的 AK 电流的特性
  • 批准号:
    6041259
    6041259
  • 财政年份:
    1995
  • 资助金额:
    $ 14.57万
    $ 14.57万
  • 项目类别:
Properties of Ion Channels that Control Secretion
控制分泌的离子通道的特性
  • 批准号:
    7474727
    7474727
  • 财政年份:
    1995
  • 资助金额:
    $ 14.57万
    $ 14.57万
  • 项目类别:
Properties of Ion Channels that Control Secretion
控制分泌的离子通道的特性
  • 批准号:
    7255796
    7255796
  • 财政年份:
    1995
  • 资助金额:
    $ 14.57万
    $ 14.57万
  • 项目类别:
PROPERTIES OF K+ CURRENT THAT CONTROLS SECRETION
控制分泌的 K 电流的特性
  • 批准号:
    2458833
    2458833
  • 财政年份:
    1995
  • 资助金额:
    $ 14.57万
    $ 14.57万
  • 项目类别:
PROPERTIES OF A K+ CURRENT THAT CONTROLS SECRECTION
控制节流的 AK 电流的特性
  • 批准号:
    6476205
    6476205
  • 财政年份:
    1995
  • 资助金额:
    $ 14.57万
    $ 14.57万
  • 项目类别:
Properties of Ion Channels that Control Secretion
控制分泌的离子通道的特性
  • 批准号:
    7097929
    7097929
  • 财政年份:
    1995
  • 资助金额:
    $ 14.57万
    $ 14.57万
  • 项目类别:
PROPERTIES OF A K+ CURRENT THAT CONTROLS SECRECTION
控制节流的 AK 电流的特性
  • 批准号:
    6624887
    6624887
  • 财政年份:
    1995
  • 资助金额:
    $ 14.57万
    $ 14.57万
  • 项目类别:

相似国自然基金

合子VegT 基因在细胞迁移和胚层形态建成的功能
  • 批准号:
    90408001
  • 批准年份:
    2004
  • 资助金额:
    100.0 万元
  • 项目类别:
    重大研究计划

相似海外基金

Ion Channel Function and Regulation of the Polycystin-1/2 Complex in Kidney Physiology and Polycystic Kidney Disease
多囊蛋白-1/2复合物在肾脏生理学和多囊肾病中的离子通道功能和调节
  • 批准号:
    10405087
    10405087
  • 财政年份:
    2020
  • 资助金额:
    $ 14.57万
    $ 14.57万
  • 项目类别:
Ion Channel Function and Regulation of the Polycystin-1/2 Complex in Kidney Physiology and Polycystic Kidney Disease
多囊蛋白-1/2复合物在肾脏生理学和多囊肾病中的离子通道功能和调节
  • 批准号:
    10665001
    10665001
  • 财政年份:
    2020
  • 资助金额:
    $ 14.57万
    $ 14.57万
  • 项目类别:
Ion Channel Function and Regulation of the Polycystin-1/2 Complex in Kidney Physiology and Polycystic Kidney Disease
多囊蛋白-1/2复合物在肾脏生理学和多囊肾病中的离子通道功能和调节
  • 批准号:
    10029791
    10029791
  • 财政年份:
    2020
  • 资助金额:
    $ 14.57万
    $ 14.57万
  • 项目类别:
Ion Channel Function and Regulation of the Polycystin-1/2 Complex in Kidney Physiology and Polycystic Kidney Disease
多囊蛋白-1/2复合物在肾脏生理学和多囊肾病中的离子通道功能和调节
  • 批准号:
    10197924
    10197924
  • 财政年份:
    2020
  • 资助金额:
    $ 14.57万
    $ 14.57万
  • 项目类别:
Identification of CALHM proteins as ion channels
CALHM 蛋白作为离子通道的鉴定
  • 批准号:
    10044119
    10044119
  • 财政年份:
    2020
  • 资助金额:
    $ 14.57万
    $ 14.57万
  • 项目类别: